TY - JOUR
T1 - Pharmacology of antiviral chemotherapeutic agents useful in human viral infections of the nervous system
AU - McKendall, R. R.
PY - 1982
Y1 - 1982
N2 - Several drugs that have antiviral activity and acceptably low toxicity for systemic use in humans have been discussed in this paper. For ara-A, acycloguanosine, and interferon, there is convincing evidence of effectiveness in limiting certain viral diseases of the nervous system. At this moment use of these drugs cannot be justified for benign, self-limiting, and uncomplicated viral diseases (e.g., localized herpes labialis). However, data from large controlled clinical trials are just beginning to be available and therefore the indications for use of these drugs may change rapidly. It is anticipated that these drugs will have a definite and welcome role in medical therapeutics.
AB - Several drugs that have antiviral activity and acceptably low toxicity for systemic use in humans have been discussed in this paper. For ara-A, acycloguanosine, and interferon, there is convincing evidence of effectiveness in limiting certain viral diseases of the nervous system. At this moment use of these drugs cannot be justified for benign, self-limiting, and uncomplicated viral diseases (e.g., localized herpes labialis). However, data from large controlled clinical trials are just beginning to be available and therefore the indications for use of these drugs may change rapidly. It is anticipated that these drugs will have a definite and welcome role in medical therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=0020323216&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020323216&partnerID=8YFLogxK
U2 - 10.1097/00002826-198205010-00006
DO - 10.1097/00002826-198205010-00006
M3 - Review article
C2 - 7046922
AN - SCOPUS:0020323216
SN - 0362-5664
VL - 5
SP - 115
EP - 129
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
IS - 1
ER -